Correlation
The correlation between RVTY and ABT is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
RVTY vs. ABT
Compare and contrast key facts about Revvity Inc. (RVTY) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RVTY or ABT.
Performance
RVTY vs. ABT - Performance Comparison
Loading data...
Key characteristics
RVTY:
-0.48
ABT:
1.63
RVTY:
-0.65
ABT:
2.31
RVTY:
0.92
ABT:
1.30
RVTY:
-0.34
ABT:
1.32
RVTY:
-1.45
ABT:
7.79
RVTY:
13.05%
ABT:
4.32%
RVTY:
34.45%
ABT:
20.95%
RVTY:
-92.39%
ABT:
-45.66%
RVTY:
-54.66%
ABT:
-4.29%
Fundamentals
RVTY:
$10.66B
ABT:
$232.41B
RVTY:
$2.42
ABT:
$7.75
RVTY:
37.36
ABT:
17.24
RVTY:
0.68
ABT:
4.17
RVTY:
3.85
ABT:
5.49
RVTY:
1.40
ABT:
4.74
RVTY:
$2.77B
ABT:
$42.34B
RVTY:
$1.56B
ABT:
$23.67B
RVTY:
$846.87M
ABT:
$11.20B
Returns By Period
In the year-to-date period, RVTY achieves a -18.88% return, which is significantly lower than ABT's 19.27% return. Over the past 10 years, RVTY has underperformed ABT with an annualized return of 5.90%, while ABT has yielded a comparatively higher 12.68% annualized return.
RVTY
-18.88%
-2.67%
-22.04%
-17.03%
-15.26%
-1.87%
5.90%
ABT
19.27%
2.06%
13.58%
33.34%
6.44%
8.99%
12.68%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RVTY vs. ABT — Risk-Adjusted Performance Rank
RVTY
ABT
RVTY vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Revvity Inc. (RVTY) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RVTY vs. ABT - Dividend Comparison
RVTY's dividend yield for the trailing twelve months is around 0.31%, less than ABT's 1.71% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RVTY Revvity Inc. | 0.31% | 0.25% | 0.26% | 0.20% | 0.14% | 0.20% | 0.29% | 0.36% | 0.38% | 0.54% | 0.52% | 0.64% |
ABT Abbott Laboratories | 1.71% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
RVTY vs. ABT - Drawdown Comparison
The maximum RVTY drawdown since its inception was -92.39%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for RVTY and ABT.
Loading data...
Volatility
RVTY vs. ABT - Volatility Comparison
Revvity Inc. (RVTY) has a higher volatility of 12.97% compared to Abbott Laboratories (ABT) at 5.67%. This indicates that RVTY's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RVTY vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Revvity Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RVTY vs. ABT - Profitability Comparison
RVTY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Revvity Inc. reported a gross profit of 375.55M and revenue of 664.76M. Therefore, the gross margin over that period was 56.5%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
RVTY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Revvity Inc. reported an operating income of 72.23M and revenue of 664.76M, resulting in an operating margin of 10.9%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
RVTY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Revvity Inc. reported a net income of 42.24M and revenue of 664.76M, resulting in a net margin of 6.4%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.